Jennison Associates’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,997
Closed -$873K 583
2022
Q4
$873K Sell
10,997
-1,541
-12% -$109K ﹤0.01% 509
2022
Q3
$759K Buy
+12,538
New +$810K ﹤0.01% 534
2021
Q3
Sell
-24,196
Closed -$978K 662
2021
Q2
$978K Sell
24,196
-893
-4% -$37K ﹤0.01% 631
2021
Q1
$1.03M Sell
25,089
-23,346
-48% -$871K ﹤0.01% 621
2020
Q4
$1.41M Sell
48,435
-4,621
-9% -$120K ﹤0.01% 551
2020
Q3
$1.17M Buy
+53,056
New +$1.35M ﹤0.01% 540

Other funds holding ACLS

Jennison Associates's ACLS Position: Q1 2023 in Review

Jennison Associates sold out of Axcelis (ACLS) in Q1 2023, closing a stake of 10,997 shares — an estimated $873K sold.

Jennison Associates first reported a position in ACLS in Q3 2020 and held it in 6 quarters. The position peaked at $1.41M in Q4 2020. 378 funds tracked by Wall St. Rank hold ACLS as of Q1 2023.

  • Jennison Associates reported no remaining Axcelis position as of Q1 2023 after selling out during the quarter.
  • Jennison Associates sold 10,997 Axcelis shares in Q1 2023, an estimated $873K.
  • Jennison Associates first reported a position in Axcelis in Q3 2020 and held it in 6 quarters.
  • Jennison Associates's Axcelis position peaked at $1.41M in Q4 2020.
  • 378 funds tracked by Wall St. Rank held Axcelis as of Q1 2023.

Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.